Aedes: What Do We Know about Them and What Can They Transmit? by Das, Biswadeep et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Aedes: What Do We Know about 
Them and What Can They 
Transmit?
Biswadeep Das, Sayam Ghosal and Swabhiman Mohanty
Abstract
Mosquitoes thrive mostly in the tropics and act as the vectors of some of 
the most debilitating human diseases caused by bioagents. Among the plethora 
of mosquitoes, Aedes transmit arboviruses, which have caused large-scale 
outbreaks throughout the world. Stegomyia is the most important subgenus of 
Aedes, which includes Ae. aegypti and Ae. albopictus vectors that are widespread 
and transmit a wide variety of arbovirus belonging to Togaviridae with the 
genus Alphavirus (Sindbis virus, equine encephalitis viruses, chikungunya 
virus), Flaviviridae with the genus Flavivirus (yellow fever virus, dengue 1–4 
viruses, West Nile virus, Japanese and St. Louis encephalitis/SLE-viruses) 
and the Bunyaviridae with the genera Bunyavirus (California Group), and 
Phlebovirus (Rift Valley fever). In India, dengue and chikungunya are the most 
important arboviral diseases transmitted by Ae. aegypti and Ae. albopictus in 
recent time. Chikungunya and dengue are acute debilitating arthritogenic and 
hemorrhagic (dengue) disease, caused by enveloped single-stranded RNA virus 
belonging to Alphavirus and Flavivirus, respectively. In this chapter, we will 
comprehensively delineate the taxonomy of Aedes mosquitoes, their geographi-
cal distribution, evolutionary biology of chikungunya and dengue viruses, 
mechanism of transmission, and proposed vector control strategies against 
Aedes mosquitoes.
Keywords: Aedes, taxonomy, vector borne disease, chikungunya, dengue, phylogeny, 
Wolbachia
1. Introduction
1.1 Aedes mosquito: overview
1.1.1 Brief account on mosquitoes
Mosquitoes are one of the most important groups of insects, because of their 
significance to humans and animals as vectors of some of the most debilitating 
diseases. They are small, two-winged insects and found mostly living in the humid 
tropics and subtropics. Mosquitoes are widely investigated by the researchers 
because they act as the vectors for a variety of pathogens and parasites including 
viruses, bacteria, protozoans and nematodes.
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Figure 1. 
Classification of Aedes up to the subgenus level showing few important species of the medically important 
subgenus Stegomyia.
1.1.2 Mosquito systematics and classification of Aedes
Mosquitoes are placed in the family Culicidae, suborder Nematocera of the 
order Diptera (the two-winged flies or true flies). The Culicidae family contains 
over 3200 species and are divided into 3 subfamilies: Anophelinae, Culicinae, 
and Toxorhynchitinae [1]. Subfamily Toxorhynchitinae comprises a single genus, 
Toxorhynchites comprising about 76 species. Toxorhynchites are not considered as 
medically important, because both sexes of Toxorhynchitinae possess a proboscis 
which curves backwards, thereby making them incapable of piercing the skin 
and transmitting disease in comparison to Anophelinae and Culicinae. There 
are three genera Anophelinae subfamily, however; only Anopheles is of medical 
importance [2]. There about 60 species of Anopheles mosquitoes which are known 
to be vectors of malaria [3]. Culicinae are the major vectors of arboviruses and 
filariasis. Medically most important genera in subfamily Culicinae are Culex, Aedes, 
Mansonia, Haemagogus, and Sabethes [3, 4].
There are more than 2500 species of Culicinae, with Aedes being the major 
genus, belonging to tribe Aedini [4]. Aedini is the largest tribe of family Culicidae 
with currently comprising 1240 recognized species. The traditional classification of 
Aedini is based on the concept of identifying few genera and numerous subgenera 
[5, 6]. The tribe Aedini was considered as a natural group; however, it was noted 
that some members showed affinities with all other higher-level taxa of subfam-
ily Culicinae [6]. Species of the tribe Aedini vary extremely and are difficult to 
identify at the genus level because of overlapping suites of similar morphological 
features. Hence, different combinations of attributes are required to clarify the 
majority of the genera, subgenera and species. General characteristics of the tribe 
include the presence of toothed ungues (tarsal claws) and a pointed abdomen 
in most females. The traditional classification of Aedini prior to the end of the 
twentieth century comprised nine genera and 50 subgenera [7, 8]. Aedes was by far 
the largest genus comprising about 1000 species and further subdivided into 41 
subgenera. Reclassification of genus Aedes began with the elevation of Verrallina 
and Ayurakitia to generic status [9, 10], followed by subsequent separation of the 
remaining subgenera into genera Aedes and Ochlerotatus [11]. Huge controversies 
3Aedes: What Do We Know about Them and What Can They Transmit?
DOI: http://dx.doi.org/10.5772/intechopen.81363
have aroused after the reclassification, especially after upgrading Ochlerotatus 
group to generic status, due to which correct classification of Aedes still remains a 
paradigm [12]. Genus Aedes is further subdivided into several subgenera comprising 
over 900 species (Figure 1). Subgenus Stegomyia comprises most of the medically 
important Aedes species which are best known vectors of yellow fever, dengue fever, 
 chikungunya fever and some forms of filariasis and other viral diseases [3].
1.1.3 The life cycle of Aedes mosquito
Like all other Dipterans, Aedes mosquitoes are holometabolous insects, meaning 
that they undergo a complete metamorphosis process, starting with an egg, larva, 
pupa, and adult stage.
The adult life span can range from 2 weeks to a month depending on environ-
mental conditions [13]. Most species are unautogenous, that means after copulation 
the females have to take a blood meal to complete egg development: Eggs: after tak-
ing a complete blood meal, females produce on an average 100–200 eggs per batch; 
however, the number of eggs produced is dependent on the size of the blood meal. 
Eggs are laid on damp surfaces in areas likely to temporarily flood, such as tree holes 
and man-made containers, and are laid singly, rather than in a mass. Generally, eggs 
are positioned at varying distances above the water line, and the female mosquito 
does not lay the entire clutch at a single site; instead, it spreads out the eggs over two 
Figure 2. 
(a) General morphological parts of an Aedes mosquito and (b) thorax of adult female Ae. aegypti and Ae. 
albopictus mosquito.
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or more sites [14]; Larvae: mosquito larvae are often called “wrigglers” or “wig-
glers,” because they appear to wiggle sporadically in the water upon disturbance. 
Aedes larvae breathe oxygen through a posteriorly located siphon that is held above 
the water surface, whereas the rest of the body hangs vertically. Larvae are generally 
found around homes in puddles, pots, cement tanks, tree holes, tires, or within any 
receptacle retaining water. Larval development is dependent on temperature. The 
larvae transition through four instars, spending a small duration in the first three 
instars, and up to 3 days in the fourth instar. Fourth instar larvae are approximately 
eight millimeters long and are vigorous feeders. Males generally pupate earlier 
because they develop faster than females. If the environmental temperatures are 
cool, Ae. aegypti can remain in the larval stage for months until the water supply 
is sufficient [14]; Pupae: after the fourth instar, Aedes larvae enter the pupal stage. 
Pupae, also called “tumblers,” do not feed and take around 2–3 days to develop. 
Adults emerge by ingesting air to expand the abdomen thus splitting open the pupal 
case and emerge head first; Adult: Aedes adults can be remarkably distinguished 
from other mosquitoes by observing the whole body, which is striped, and so called 
“decorative mosquito” which is more distinct on the legs and scutellum, with short 
palpi and more or less pointed abdomen with pale bands. For example, adult Ae. 
aegypti and Ae. albopictus are often differentiated by the white scale bands on the 
dorsal part of the thorax. In case of Ae. aegypti, the pattern comprises two straight 
lines surrounded by curved lyre-shaped lines on the side. In contrast, a single broad 
line of white scales in the middle of the thorax is present in Ae. albopictus [15] 
(Figure 2).
1.1.4 Arbovirus and Aedes mosquitoes
Arboviruses (arthropod-borne-viruses) are defined as the viruses, which mul-
tiply within arthropods and can be transmitted by the arthropods to vertebrates. 
Usually, the arthropod gets infected by feeding on the blood from an infected ver-
tebrate during viremia (virus circulation in the peripheral blood vessels), and then 
the virus can be transmitted to another vertebrate-host (horizontal transmission) 
after proliferation in the vector. Arboviruses can also be passed from one arthro-
pod generation to another by transovarian transmission (vertical transmission). 
Several species of Aedes transmit arbovirus, which have caused large scale outbreaks 
throughout the world. Stegomyia is the most important subgenus of Aedes from 
medical point of view, followed by subgenus Finlaya, Aedimorphus and Diceromyia. 
Ae. aegypti, Ae. albopictus, Ae. vittatus, Ae. scutellaris, Ae. pseudoscutellaris, Ae. 
polynesiensis, Ae. bromeliae and Ae. africanus are the important vectors of subgenus 
Stegomyia that transmit several arboviral diseases across the world, out of which 
Ae. aegypti and Ae. albopictus are the most important vectors that are widespread 
and transmit a wide variety of arbovirus belonging mainly to three families: the 
Togaviridae comprising the genus Alphavirus (e.g., Sindbis virus, equine encephali-
tis viruses, chikungunya virus), Flaviviridae with the genus Flavivirus (e.g., yellow 
fever virus, dengue 1–4 viruses, West Nile virus, Japanese and St. Louis encepha-
litis/SLE-viruses) and the Bunyaviridae comprising the genera Bunyavirus (e.g., 
California Group), and Phlebovirus (Rift Valley fever) [16]. Ae. poicilius, Ae. togoi, 
Ae. kochi, Ae. niveus, and Ae. harinasutai of subgenus Finlaya are important vectors 
of arboviruses and microfilariae in the Oriental Region. Ae. vexans of the subgenus 
Aedimorphus has an extensive distribution in tropical Africa, Central America, 
Southeast Asia, and temperate regions of the Nearctic and Palaearctic Regions. Two 
species of the subgenus Diceromyia, Ae. taylori and Ae. furcifer have been implicated 
in the transmission of yellow fever virus and the spread of chikungunya virus in 
Africa [17].
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In India, dengue and chikungunya are the most important arboviral diseases that 
are transmitted mainly by Ae. aegypti and Ae. albopictus and have caused massive 
and unprecedented outbreaks in recent times, thereby causing huge loss of lives and 
economic burden to the nation [18–20].
1.2 Chikungunya: overview
1.2.1 History and phylogenetics of CHIKV evolution
CHIKV was first isolated and characterized in 1953 during an epidemic of febrile 
polyarthritis in Tanzania (formerly Tanganyika) [21]. The word “chikungunya” comes 
from ChiMakonde, the language spoken by the Makonde people, an ethnic group in 
southeast and northern Mozambique meaning “that which contorts or bends up” and 
refers to the stooping posture of infected patients due to severe joint pain.
Since the 1953 Tanzania outbreak, CHIKV has caused outbreaks in various parts of 
Africa. The re-emergence of CHIKV epidemic in Africa was documented in 1999–
2000 in Kinshasa where an estimated 50,000 persons were infected. The first docu-
mented Asian outbreak took place in 1958 in Bangkok, Thailand. Since then, many 
outbreaks have been recorded from Cambodia, Vietnam, Laos, Myanmar, Malaysia 
and Indonesia. There is historical evidence that chikungunya virus originated in 
Africa and subsequently spread to Asia [22]. Phylogenetic analysis of CHIKV virus 
sequences originally identified three distinct clades separated primarily by geography 
designated the West African, Central/East African (ECSA) and Asian genotypes. 
The Asian genotypes have a high degree of sequence identity among themselves 
whereas the African strains exhibit wider sequence diversity and have been shown to 
undergo genetic microevolutions even during the course of an epidemic [23]. Recent 
phylogenetic studies showed that the Indian Ocean and Indian subcontinent out-
breaks were caused by virus strains of the Indian Ocean lineage (IOL), which evolved 
from the ECSA genotype [19, 24]. This lineage first emerged in Kenya in 2004, and 
subsequently spread to several Indian Ocean islands, India and Southeast Asia. The 
IOL strains involved in the Indian Ocean and Indian outbreaks possessed the initial 
adaptive mutation, E1-A226V [25], which is a major genetic determinant of adapta-
tion of CHIKV to Ae. albopictus vector species and provides a plausible explanation for 
how this mutant CHIKV caused epidemics in regions lacking the more typical urban 
vector, Ae. aegypti [26]. Introduction of new viral strains, viz. IOL strains inevitably 
leads to the question whether particular genotypes of CHIKV are associated with 
higher virulence or severe disease. In addition, the lack of a suitable animal model for 
CHIKV makes it difficult to verify such hypotheses [27]. On the other hand, associa-
tion of the re-emergence of endemic strains with the outbreaks leads to a different 
question that can be clarified only by a combination of classic epidemiology and com-
parative genomics: whether the viruses re-emerged due to environmental, population 
immunity and/or vectorial factors, or whether outbreaks were triggered by adaptive 
evolution of the virus that endowed it with an increase in fitness and virulence? 
Therefore, knowledge of the complete genetic blueprint of CHIKV is essential for 
clarifying these crucial questions.
1.2.2 Chikungunya virus (CHIKV): genome structure and organization
Chikungunya is an acute debilitating arthritogenic disease, caused by 
 chikungunya virus (CHIKV) belonging to Alphavirus genus; family Togaviridae, 
which consists of Alphavirus and Rubivirus genera. Approximately, 40 alphaviruses 
can infect vertebrates such as humans, rodents, birds, and horses, along with inver-
tebrates. Mosquito vectors are responsible for the transmission between species, 
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thereby rendering alphaviruses to be considered as arboviruses. CHIKV is an 
enveloped particle and has a single-stranded RNA genome of positive polarity. The 
genome is approximately 11.8 kb in length [28]. Under electron microscopy in green 
monkey kidney (Vero) cells CHIKV particles reveal a characteristic Alphavirus 
morphology.
CHIKV genome consists of polyadenylated RNA and is capped, which encodes 
two open reading frames (ORFs). Two-third of the genome includes the 5′ ORF that 
encodes four nonstructural proteins, which are involved in genome replication, cap-
ping of RNA, polyprotein cleavage, etc., essential for viral replication. This region 
is expressed as an nsP1-3 or nsP1-4 polyprotein via cap-dependent translation, 
which is further cleaved by an nsP2-encoded protease. In context to the structural 
protein ORF, it is embedded in a subgenomic mRNA, and is translated into proteins 
via a cap-dependent mechanism. This structural ORF polyprotein is finally cleaved 
into capsid, envelope glycoproteins E1, and glycoprotein E2. The mature virion 
comprises 240 heterodimers of E2/E1, which are arranged as trimeric spikes on its 
surface, and has a diameter of 70 nm (Figure 3). After being translocated by the 
secretory pathway, these heterodimer spikes penetrate into the plasma membrane 
of infected cells, and cytoplasmic nucleocapsids containing the genomic RNA and 
240 copies of the capsid protein bud from the cell surface for assembly of the virion 
envelope and envelope protein spikes [28].
During early infection, the nonstructural proteins are synthesized directly from 
the two third of genomic RNA as a P1234 polypeptide that is further cleaved to 
form Nsp1, Nsp2, Nsp3, and Nsp4 nonstructural proteins. Nsp1 protein is involved 
in the synthesis of minus-strand RNA, in addition to building association of the 
replication complex with cellular membranes. Nsp2 protein acts as a helicase 
and proteinase that cleaves the nonstructural polyprotein to form the individual 
Figure 3. 
CHIKV genome, binding, and entry into host cells followed by replication.
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nonstructural proteins [30]. The function of Nsp3 in viral replication is largely 
unknown, however, it is probably involved in RNA synthesis [28]. Nsp4 interacts 
with the N terminal region and other nonstructural proteins and host factors, and 
acts as the viral RNA polymerase. The sub-genomic mRNA (26S) synthesizes single 
polypeptide that comprises the structural proteins, such as capsid, E3, E2, 6K and 
E1. These proteins are then cleaved co-translationally and post translationally to 
form the functional structural proteins. These structural proteins have important 
functions during virus replication and particularly, in the interaction with the host. 
Such interaction with the host was first presented by the production of antibodies 
that played important roles in the recovery from infection [31].
The region between the nonstructural and structural domains is called the 
“junction region,” which enhances the transcription of an intracellular subgenomic 
26S RNA. There are two other untranslated regions, along with the junction region; 
one at the 5′-end, which is required for the synthesis of the plus-strand [25], and 
the other at the 3′ end between the stop codon of the E1 gene and the poly (A) tail. 
This region is mainly involved in translation of viral proteins rather than in replica-
tion of the genomic RNA [28, 32].
1.2.3 Replication cycle of CHIKV
The interaction between the envelope proteins of CHIKV and receptors of host 
cells is required to penetrate into vertebrate cells. The cellular receptors for CHIKV 
are still unknown; however, in other Alphavirus the laminin receptor, glycosami-
noglycans and DC-SIGN (CD209) molecules are involved in viral uptake [33]. The 
virus is transported into the cell by endocytosis of clathrin-coated vesicles. The 
activation of E1 protein from the E1-E2 complex is initiated because of the pH 
reduction of the vesicle, thereby initiating fusion of viral and endosomal mem-
branes, resulting in the release of the nucleocapsid into the cytoplasm. Replication 
of CHIKV occurs in the cytoplasm. The first event is P1234 precursor polyprotein 
translation and RNA replication. P1234 polyproteins are directly translated from 
the viral genome, followed by the initiation of RNA replication through the synthe-
sis of a complete minus-strand RNA, which serves as the template for the synthesis 
of the viral genome and for the transcription of 26S subgenomic plus-strand RNA 
from the internal promoter of the junction region. As both processes are inter-
linked, Nsp4 associates with P123 and other host factors to regulate the synthesis 
of minus-strand RNA, after cleavage from the P1234 polyprotein. This switching 
from genome replication to transcription of sub-genomic 26S positive-strand RNA 
is also regulated by the nonstructural proteins that were cleaved from the P123 
polyproteins [34]. The 26S subgenomic RNA that serves as the mRNA translates 
the structural protein precursor, and further undergoes co-translational cleavage 
to become mature (C-E3-E2-6 k-E1). Autocatalytic cleavage of the N-terminal 
region of structural polyprotein precursor generates the capsid protein, followed by 
encapsidation of the viral genomic RNA, thereby, resulting in the rapid assembly 
of nucleocapsid cores in the cytoplasm. In parallel, E2 and E1 are transferred to the 
plasma membrane after being cleaved from the envelope polyprotein precursor. 
Finally, the packaging of the virus is performed in the cytoplasm by the assembly of 
nucleocapsid cores along with glycoproteins, and the virus is released by budding 
through the cellular membrane to form an enveloped virion [34].
1.2.4 Clinical presentations of CHIKV
The most common symptom in chikungunya disease is painful polyarthralgia, 
mainly bilateral, symmetrical and culminates within few days usually affecting 
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peripheral joints like ankles, toes, fingers, elbows, wrists and knees. The joints 
exhibit extreme tenderness and swelling with patients frequently reporting inca-
pacitating pain that lasts for weeks or months. Other typical signs for CHIKV infec-
tion include fever, headache, retro-orbital pain, chills, weakness, lumbar back pain, 
joint stiffness, malaise, nausea and a rash that may or may not be accompanied 
by other signs and symptoms of the disease [35]. The acute illness lasts 3–5 days, 
with recovery in 5–7 days. The incubation period following the bite of an infected 
mosquito is short (2–6 days) and ends with a sudden onset of fever reaching as high 
as 104°F that may last up to 10 days. The fever almost always precedes the rash and 
joint pain and only very rarely has been reported as biphasic with recurrence noted 
on the fourth or fifth day of illness. The rash, appearing primarily on the trunk, 
face, and limbs of the body is visible on day 2–5 postinfection, and may last up to 
10 days. Older patients with an history of rheumatism exhibit more severe symp-
toms in comparison to younger patients [36].
1.2.5 Pathogenesis and diagnosis of CHIKV
Detailed studies on the pathogenesis of the chikungunya fever are rare. It is 
hypothesized that after inoculation, primary viral multiplication occurs in lym-
phoid and myeloid cells. The arthropod vectors acquire the virus by sucking blood 
during this period. The virus, then spreads to the targeted organs and immune 
system starts functioning at this stage, leading to the activation of both humoral 
and cellular immunity. This response of the body leads to the development of clini-
cal features of the disease [36].
The probable diagnosis of chikungunya fever can be made on the basis of the 
presence of the virus in the community, and a clinical trial of fever, rashes and 
arthralgia, which are suggestive of the illness. The virus produces neutralizing and 
haemagglutination inhibiting (HI) antibodies, which helps in serological diagnosis. 
HI test is the simplest diagnostic test; however, it identifies the group rather than 
specific virus. Confirmation of the illness is done by detection of the antigen or 
antibody to the analyte in the blood sample of patient [37]. Reverse transcriptase 
polymerase chain reaction (RT-PCR) is a confirmatory test for the identification of 
CHIKV. IgM capture ELISA is the most sensitive serological assay, and can distin-
guish the chikungunya from dengue. All virus isolation procedures need to be done 
under bio safety level 3 (BSL-3) precautions, although such precautions may not be 
necessary in the countries where CHIKV is endemic.
1.2.6 Transmission cycles of CHIKV
CHIKV is transmitted by mosquitoes belonging to genus Aedes. The mosquitoes 
considered to be the main vectors for CHIKV are Ae. albopictus and Ae. aegypti [3]. 
Continuous variations in the geographic distribution of these vectors have been 
documented in several studies. Ae. aegypti was considered to be the primary vector 
of CHIKV in most parts of the globe [38], whereas Ae. albopictus (common name 
Asian tiger mosquito) was considered to be the secondary vector and was restricted 
to Asia [38]. However, the recent reemergence of CHIKV in many parts of the world 
has been mainly associated with Ae. albopictus vector [19, 38]. Furthermore, reports 
indicate Ae. albopictus to replicate and transmit the old African genotype of CHIKV 
as well as the recent Indian Ocean strain of CHIKV better than those of Ae. aegypti 
and other Aedes species [39]. CHIKV is endemic in tropical regions of Africa and 
Asia, where the mechanisms of CHIKV transmission and maintenance appears to 
be very complex and vary significantly depending on the particular region where 
virus activity is detected.
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1.2.7 CHIKV in African mosquito vectors
In Africa, CHIKV is believed to be maintained in a sylvatic as well as with urban/
rural cycle involving wild nonhuman primates and forest-dwelling Aedes mos-
quitoes (Figure 4). Several field studies conducted in Senegal, Nigeria, Uganda, 
Tanzania, Cote d’Ivoire, Central African Republic and South Africa concluded that 
the main sylvatic vectors of CHIKV are probably Ae. furcifer, Ae. taylori, Ae. africa-
nus, Ae. luteocephalus and Ae. Neoafricanus [32]. Based on the isolation frequencies, 
it appears that Ae. furcifer and Ae. taylori are more important in southern and west-
ern Africa, while Ae. africanus is the chief vector in central regions [35]. Laboratory 
studies have confirmed vector competence of Aedine sylvatic mosquitoes in Africa. 
In South Africa, the oral infectious dose of Ae. furcifer was 50% (OID50)—the titer 
of the virus in the blood meal sufficient to infect 50% of mosquitoes was found to 
be less than 6.2 log/ml resulting in a transmission rate of 25–32%. This is sufficient 
to sustain CHIKV transmission from velvet monkeys and baboons, which develop 
viremia up to 7–8 log/ml [41].
1.2.8 CHIKV circulation in Asian mosquito vectors
In contrast to Africa, only urban/rural CHIKV transmission cycle has been 
described in Asia (Figure 4). Ae. aegypti is the main vector of CHIKV and Ae. 
albopictus is believed to play a secondary role in several outbreaks. CHIKV 
epidemics in humans seem to be disconnected from zoonotic transmission, 
however; the recent study of seroprevalence to CHIKV infection among wild 
monkeys in the Philippines showed presence of anti-CHIKV IgG in 59.3% of 
animals tested, suggesting existence of a possible sylvatic transmission cycles 
[42]. Currently, it is believed that persistence of CHIKV in Asia results from viral 
migration back and forth among different locations sustained by the human-Ae. 
aegypti cycle [43].
The vectors responsible for viral transmission during these epidemics have not 
been definitely characterized. Both Ae. aegypti and Ae. albopictus are present in 
India and their epidemiologic significances for CHIKV transmission probably vary 
Figure 4. 
CHIKV transmission cycle in Asia and Africa (modified from Thiboutot et al. [29, 40]).
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dependent on the geographic location. Another intriguing feature of the 2006–2008 
CHIKV epidemic in India, beside the magnitude, is the fact that this epidemic was 
caused by virus of the ECSA genotype. All previous outbreaks were caused by Asian 
genotype of CHIKV. It was proposed that this shift in viral genotype was the major 
factor in the re-emergence of Chikungunya in an unprecedented outbreak in India 
after a gap of 32 years [44].
1.3 Dengue: overview
1.3.1 History and geographic distribution of DENV
DENV is found in tropical and subtropical areas throughout the world, with 
prevalence in both urban and suburban areas. DENV is endemic in more than 
one-hundred countries with more than two-and-a-half billion people and around 
40% of the world’s population living in areas at risk for infection. The World Health 
Organization estimates that there are between fifty and one-hundred million DENV 
infections each year, causing hospitalization of five-hundred thousand people, 
and a death rate of two-and-a-half percent [45]. The earliest report of disease with 
dengue-like symptoms dates back to a Chinese encyclopedia of disease symptoms 
and remedies that was published from 265 to 420 A. D during the Chin Dynasty 
[46]. It is speculated that DENV was the etiological agent during disease outbreaks 
in the French West Indies in 1635, in Panama in 1699, and the Philadelphia epidemic 
of 1780 [47]. Reported cases of dengue disease were seen in 1779 and 1780 in Africa, 
Asia, and North America [48]. The first verified dengue epidemic occurred from 
1953 to 1954 in the Philippines followed by a quick global spread of epidemics of 
DF/DHF. In the 1980s and 1990s, DENV continued to expand, and reached areas 
with mosquito vectors [49].
The very first report of the existence of dengue fever in India was in 1946 from 
US soldiers in Kolkata [50]. Since then, there was no significant dengue activity 
reported anywhere in the country for the next 18 years. In 1963–1964, an epidemic 
of dengue fever was reported from the Eastern Coast of India, further spreading 
northwards and reached Delhi in 1967 and Kanpur in 1968. Simultaneously, the 
DENV epidemic also engulfed the southern part of the country and gradually 
the whole country was affected by wide spread epidemics followed by endemic/
hyperendemic prevalence of all the four serotypes of DENV. However, most dengue 
outbreaks in India were simple dengue fever with very rare cases of DHF/DSS 
epidemics. The first major wide spread epidemics of DHF/DSS occurred in 1996 in 
India, involving areas around Delhi and Lucknow, further spreading across the 
country [51, 52]. Since then, the epidemiology of DENV and its prevalent serotypes 
has been frequently changing in India.
1.3.2 Dengue virus (DENV)
Dengue virus (DENV) is a member of enveloped, positive-strand RNA viruses 
of the flaviviridae family. The flaviviridae family also includes West Nile virus, 
yellow fever virus, Japanese encephalitis virus, hepatitis C virus, and tick-borne 
encephalitis virus. Flaviviruses are transmitted to humans by arthropod vectors 
such as mosquitoes or ticks [49].
1.3.3 Dengue viral structure
There are four phylogenetically and genetically distinct, but antigenically related 
serotypes classified as DENV-1, DENV-2, DENV-3 and DENV-4. The dengue virion is 
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a spherical particle, existing as either a 50 nm diameter immature particle or a mature 
60 nm diameter particle with a lipopolysaccharide envelope. DENV genome is about 
11 kb with a single ORF encoding three structural proteins: capsid (C), membrane (M), 
and envelope (E) and seven viral encoded nonstructural proteins: NS1, NS2A, NS2B, 
NS3, NS4A, NS4B and NS5 (Halstead, 2008). DENV RNA contains a type I cap structure 
(m7GpppAmpN2), located at its 5′-end, and lacks the poly (A) tail at its 3′ end. The 
DENV genome is surrounded with C proteins and forms the inner core. The structural 
proteins E and M are surface proteins on the virion envelope and the conformations of 
these proteins are used to distinguish between immature and mature virus. The imma-
ture virus is referred to as “spiky” as M proteins bound to a precursor membrane protein 
(pr) form heterodimers with E proteins that appear as “spikes” on the viral surfaces. 
In mature virions, the soluble pr is cleaved from M protein by furin, anchoring the M 
proteins and causing the pr protein to be absent in the mature viral membrane [53].
1.3.4 Dengue viral replication
DENV enters a variety of cells including macrophages, monocytes, and dendritic 
cells though cell endocytic vesicles. The first step in DENV infection is binding to the 
cellular receptors on the surface of the target cell like ubiquitous receptor (DC-SIGN). 
This interaction leads to the internalization of the virion via receptor-mediated endo-
cytosis, resulting in the fusion of the virus with the endosomal membrane because 
of acidification, and finally releasing the viral genome into the cytoplasm. DENV 
genome is associated with rough ER (site of its translation), because the viral RNA 
can act as mRNA. Viral replication occurs in two steps: first, the positive-polarity 
RNA is copied to RNA of negative polarity that serves as a template for the synthesis 
of multiple strands of RNAs of positive polarity (amplification process); the positive-
polarity RNA can then translate into proteins, for further RNA synthesis of negative 
polarity, or can become associated with structural proteins C, E, and M to form the 
viral progeny. Second, the immature virus particles travel to the Golgi apparatus in 
vesicles, where they undergo glycosylation, and are finally transported through secre-
tory vesicles outside the cell (Figure 5). During the latter process, the furin cleaves 
prM in M to generate mature virions, which is the final step of viral morphogenesis 
[55]. The three main elements that are necessary for DENV replication are: cis-acting 
elements, trans-acting factors, and viral induced membranes.
1.3.4.1 Cis-acting elements
The cis-acting elements are mainly located at both ends of DENV genome in the 
5′- and 3´-UTR. The cyclization sequences, as well as the upstream UAG region located 
at both ends of DENV genome and the downstream AUG region induce circulariza-
tion of DENV genome. For an efficient negative-strand RNA synthesis, the secondary 
structure of the stem loop at the 3′-end (3′-SL), along with the secondary structure of 
SL structures within the 5´-UTR are essential. The initiation of viral replication occurs 
with the binding of NS5 (RNA dependent RNA-polymerase) to the 5´-UTR.
Trans-acting factors are of two types: viral trans-acting factors and cellular trans-
acting factors.
Viral trans-acting factors: NS3 and NS5 (multifunctional and multidomain 
proteins, respectively) are the only proteins encoded by DENV possessing cata-
lytic activities. NS5 has two main activities: RNA-dependent RNA-polymerase 
and methyltransferase. NS3 has protease, helicase, and nucleoside triphosphatase 
activities. NS3 functions by regulating its association with other viral proteins. NS1 
and the small nonstructural proteins are required for anchoring the viral replication 
complex to the membranes of the endoplasmic reticulum.
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Cellular trans-acting factors: several cellular proteins, such as elongation factor 1a 
(EF1a), polypyrimidine tract binding protein (PTB), LA, calreticulin, PDI, and the 
heterogenous nuclear factors A1, A2/B1 and Q, have been found to bind to the 5′- or 
3′-UTR of DENV. During DENV infection, PTB and La proteins translocate from 
the nucleus to the cytoplasm and act as the positive and negative regulators of viral 
replication, respectively. The YB-1 protein might participate in the switching from 
viral translation to replication or might have a role as an antiviral factor [54, 55].
1.3.4.2 Viral induced membranes (replication complex)
For the formation of the replication complex, proliferation and the generation 
of invaginations of the ER membranes are required initially, which are probably 
induced by NS4A and NS3 in conjunction with cellular and other viral proteins. 
Invaginations are mainly considered as the site for viral replication. The DENV 
RNA is exported to the convoluted membranes that might potentially store proteins 
and lipids required for DENV replication. Viral morphogenesis is initiated by the 
association of the RNA and the C protein generating nucleocapsids. The C protein 
accumulates around the lipid droplets in the ER. Accumulation of immature viral 
particles occurs in the lumen of dilated ER cisternae, which are then transported to 
the cis-Golgi for maturation (Figure 6) [56].
1.3.5. Classification and symptoms of dengue
Cases of symptomatic dengue have historically been classified by severity accord-
ing to WHO guidelines first published in 1975, which differentiate between cases of 
dengue fever (DF), dengue hemorrhagic fever (DHF) and dengue shock syndrome 
[3] (Figure 7). However, dengue epidemiology has changed considerably since these 
guidelines were first published, leading to difficulties with the use of this classifica-
tion system in a clinical setting. Examples of severe dengue that do not follow WHO 
criteria of DHF stratification are dengue with hemorrhage but without evidence of 
plasma leakage; dengue with shock syndrome without fulfilling all four DHF criteria; 
and severe dengue accompanied with organ dysfunction and a low level of plasma 
Figure 5. 
Picture demonstrating: gene organization in DENV RNA genome (top), membrane topology and proteolytic 
cleavage sites of the transcribed polyprotein (bottom). Arrows denote the cellular and viral proteases, which 
process the immature polyprotein into ten separate proteins (modified from Perera and Kuhn [54]).
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leakage. In view of the above facts, recently the WHO Tropical Disease Research 
(TDR), 2009 [57] proposed a new classification of dengue, i.e., dengue (D), dengue 
with warning signs (DW) and severe dengue (SD) in order to re-evaluate the current 
classification for better management of high case fatalities. However, the previous 
Figure 6. 
Dengue replication cycle. Dengue enters a susceptible cell through receptor-mediated endocytosis. In endosomic 
vesicles, dengue virions are uncoated and release the genome into the ER. Viral RNA is translated into a 
polypeptide and processed to form viral proteins. Replication and viral assembly occurs in the ER, and the virions 
travel to the Golgi for modification and is exported via exocytic vesicles (adapted from Clyde et al. [56]).
Figure 7. 
Dengue case classification [3]. Dengue cases are classified as dengue fever (DF), dengue hemorrhagic fever 
(DHF), or dengue shock syndrome (DSS) according to the clinical observations shown in the figure.
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classification of dengue [3] is still being followed in most countries for rapid diagnosis 
and prompt treatment of most cases with aggravated symptoms.
1.3.6 Pathogenesis and diagnosis of DENV
For the establishment of DENV infection in the patient, an incubation period 
generally occurs ranging between 3 and 14 days after a patient gets infected with 
DENV through the bite of an infected female Aedes mosquito. The patient subse-
quently experiences the painful febrile period when viremia is at its peak, which 
recedes in about 5–7 days after the onset of fever, coincident with defervescence. 
DHF/DSS usually develops during this time and the patient may develop intense 
clinical manifestations. If DHF develops, the patient may rapidly go into a state of 
shock and die within 12–24 hours if left untreated. After defervescence, laboratory 
diagnosis is based on IgG and IgM antibody detection. The disease progression for 
dengue is presented in the schematic form in Figure 8. The most commonly used 
diagnostic laboratory tests for DENV detection include those that detect DENVs, such 
as isolation by tissue culture and RT-PCR, and those that detect antibodies against the 
virus, such as enzyme-linked immunosorbent assay (ELISA), neutralization tests, 
haemagglutination inhibition (HI), and immunofluorescence (IF). Although the 
gold standard laboratory diagnosis of any flavivirus infection is isolation, and further 
characterization of the virus (for example by antigen detection) from the patient 
sample, it is a lengthy process and requires over a week for completion. In contrast, 
RT-PCR could be performed within hours and could therefore improve patient care. 
These detection methods are mainly used within approximately 10 days of the onset 
of symptoms because the virus is present in the sera typically till the duration of fever 
[3]. After this period, antibodies generated against DENV can be detected using 
serological methods. The antibodies neutralize DENV, and therefore, it is not possible 
to detect or culture the virus once the immune response is significantly underway.
1.3.7 Immune response and antibody-dependent enhancement (ADE)
Throughout his/her lifetime, a person can suffer from dengue infection four times 
(once for each of the four DENV serotypes). Both primary (first) and secondary 
(subsequent) infections by any DENV serotype can result in any of the two clinical 
manifestations: less severe DF or more severe DHF. A life-long immunity is conferred 
against the infecting serotype if primary infection occurs in a patient, along with a 
Figure 8. 
Course of dengue infection and the timings and choices of diagnostic methods.
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brief protection against infection by other DENV serotypes in the recovered patient. 
However, epidemiological data and some studies suggest that the immunity thus gained, 
after the lapse of the temporary cross-serotypic protection, increases the probability of 
an individual to develop DHF when infected by a second heterologous DENV serotype. 
A hypothesis that can explain this phenomenon is the antibody-dependent enhance-
ment (ADE), which states that immunocomplexes are formed between the preexisting 
sub-neutralizing antibodies from the primary infection and the second infecting DENV 
serotype, which bind to the cells bearing Fcγ receptor (FcγR) (monocytes and B cells), 
thereby, leading to increased virus uptake and replication [58] (Figure 9).
1.3.8 Vectors and transmission cycles of DENV
Dengue is transmitted from person to person through the bites of infected 
female Aedes mosquitoes. DENV is believed to have been maintained in sylvatic/
enzootic transmission cycles involving nonhuman primate hosts and vector spe-
cies living in forests. The virus was first transmitted to humans when the two 
hosts (humans and nonhuman primate) came into contact, and was, thereafter 
established in continuous human-mosquito cycles in and/or around human popula-
tion centers. Several species of the genus Aedes are known to transmit DENV; the 
principal vector is Aedes aegypti. The Australian naturalist, Thomas Lane Bancroft in 
1906 first suggested that Ae. aegypti is the carrier of dengue fever based on epidemi-
ological grounds [59]. Ae. aegypti is a day-biter that prefers to breed in domestic and 
peridomestic water containers. Its adaptation to human habitats and its desiccation-
resistant eggs have allowed it to flourish in urban centers.
Ae. albopictus, commonly known as the Asian tiger mosquito is considered as the 
secondary vector of DENV. Koizumi et al., 1917 first identified its role as the dengue 
vector in semi-tropical regions in Taiwan [60]. Ae. albopictus serves as the primary 
vector for dengue in countries where Ae. aegypti is absent and as a maintenance vector 
in rural areas where both species coexist [61]. Moreover, ecology changes and global 
urbanization have caused major changes in the vectorial behavior of the two species, 
rendering Ae. albopictus to be the major vector of arboviral diseases like dengue and 
chikungunya in many countries, like India [19, 20]. In the Pacific islands, Ae. polyne-
siensis has been suggested as the primary dengue vector, whereas Ae. scutellaris was 
identified as the “jungle” vector for dengue [62]. In the continued absence of vaccines 
and specific treatment, effective vector control (either through fogging that kills 
adult mosquitoes, application of larvicides that target the aquatic stage of mosquitoes, 
source reduction that reduces their breeding habitat or biological control methods 
employing Wolbachia to hinder the fertility of mosquitoes) is currently the only 
practical method available for reducing the incidence of dengue disease [63].
Figure 9. 
Model for antibody-dependent enhancement (ADE) of dengue virus replication.
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1.3.9 Role of phylogenetics in DENV evolution
DENV serotypes have been classified into multiple genotypes based on their 
genomic diversity. Genotype classification can often unveil the geographical origin 
of the dengue virus strains, except for the sylvatic genotypes. This has assisted 
in the temporal and spatial tracking of the virus transmission routes, which has 
served as the basis of molecular epidemiological studies, focusing on determining 
the causative agents of dengue epidemics, such as the introduction of new viruses 
and the result of re-emergence of endemic strains (Figure 10). Moreover, DENV 
has a tendency to evolve rapidly due to factors such as inter and intra serotypic 
recombination, mutation and ecological changes, thereby resulting in generation of 
new genotypes, which are more virulent, resistant and can cause massive outbreaks 
affecting large number of people. Introduction of such new viral genotypes inevi-
tably leads to the question whether particular genotypes of DENV are associated 
with higher virulence or severe disease. To date, several diseases have often been 
associated with several DENV genotypes originating in Southeast Asia. The lack of 
a suitable animal model for the dengue disease poses challenges in confirming such 
hypothesis [64].
1.4 Vector control strategies
1.4.1 Conventional vector control
Vector control programs greatly depend on the use of chemicals such as insecti-
cides like DDT, pyrethroids, organophosphates, and temephos. The annual demand 
of the insecticides amounts to more than 50,000 tons, with DDT being the most 
commonly used insecticide in the past. DDT, which is mainly used in indoor spray-
ing for the control of vectors of malaria and visceral leishmaniasis, is forbidden in 
most of the countries today after the Stockholm Convention in 2001, when it was 
discovered to be dangerous to wildlife and the environment as it can remain in the 
environment and food chain for a considerably long time. Regarding other insecti-
cides, most of them have undesirable effects besides their life-saving benefits. For 
example, vectors can become resistant and the nonbidegradability of the chemical 
frequently causes environmental damage. Although efforts have been conducted to 
develop a suitable vaccine against arboviral diseases like dengue and chikungunya, 
Figure 10. 
Dengue risk map showing the highly suitable dengue epidemic areas around the world, depicting India to be a 
high-risk zone for dengue outbreaks (adapted from Simmons et al. [63]).
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no vaccine has been developed with 100% efficacy to date. Therefore, the only 
means of reducing case fatality rate is early diagnosis and proper case management. 
The chief mode of controlling the disease is by eliminating the vector. It is of course 
much cheaper to prevent an outbreak of the disease than to diagnose and to treat 
the cases.
The major strategies for controlling Aedes vectors are: (1) reduction of Aedes 
breeding sites through environmental sanitation by the elimination of all nones-
sential water-containing receptacles. This is by far the most effective method 
in terms of long-term reduction of the mosquito population; (2) protection of 
water-containing receptacles by putting lids or covers to prevent egg laying by 
the mosquitoes; (3) release of larvivorous fish or other biological organisms as 
predators/parasites of larvae; (4) observation of a “Weekly Dry Day,” i.e., the 
containers can be emptied at least once a week through generating awareness 
among the local population; (5) cleaning the containers before and after the rainy 
season can also contribute in reducing the mosquito populations and (6) space 
spraying, for example, with malathion against adult mosquitoes and larviciding 
with temephos.
1.4.2 Wolbachia: potential biocontrol agent
Wolbachia is a bacterium belonging to the tribe Wolbachia and family 
Rickettsiaceae and order Rickettsiales. They are a widespread group of bacteria 
commonly found in the reproductive tissues of arthropods. Wolbachia have 
attracted much attention by virtue of its ability to manipulate the reproduction 
of its arthropod hosts. Mosquito vectors such as Aedes, Culex, and Anopheles 
transmit a variety of diseases like dengue, filaria, Japanese encephalitis, and 
malaria. The vectors have gained resistance against insecticide and pesticides 
due to their variant mutation in genetic constitution. The continuous use of 
insecticides for control strategies increasingly faces the problems of high cost, 
increasing mosquito resistance and negative effects on nontarget organisms. 
Wolbachia have attracted scientific interest due to their ability to manipulate host 
reproduction, leading to distinct phenotypic effects in the host such as partheno-
genesis, feminization, male killings and cytoplasmic incompatibility [65]. These 
modifications typically confer a reproductive advantage to infected individuals 
and allow the rapid spread of Wolbachia through a population [66, 67]. The most 
common effect of Wolbachia infection in mosquitoes is cytoplasmic incompat-
ibility, which was first described in Culex pipiens, when infected male mosqui-
toes mated with uninfected female mosquitoes of the same species. The ability 
of Wolbachia to manipulate its host biology enables it to increase in frequency 
in host populations without the need for horizontal transmissions [68]. Hence 
Wolbachia can be used as a potential weapon against pests and the diseases they 
can carry.
Molecular phylogeny represents a great source of information for better 
understanding the evolutionary relationships among Wolbachia to analyze 
changes occurring in different organisms during evolution. The strain variation, 
of any Wolbachia species in mosquito populations is necessary for understand-
ing the evolutionary mechanisms of Wolbachia genotypes in vector mosqui-
toes. Phylogenetic analysis of Wolbachia using different molecular markers is 
important to understand the evolution, pathogenesis and strain typing in areas 
having abundant arboviral vectors. Several molecular phylogenetic studies have 
been reported using 16S rRNA gene, ftsz cell cycle gene, wsp Wolbachia surface 
protein gene, out of which wsp gene has been the most preferred for phylogenetic 
analysis [69].
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Therefore, further studies of the natural occurrence and diversity of Wolbachia 
in the major Aedes vectors are of high interest. Ultimately, this will be useful for 
making strategies for vector control programmes by determining the specific strain 
of Wolbachia that is present in Aedes followed by artificial infection of Wolbachia 
into the major Aedes vectors that will effectively reduce their life span thereby 
reducing disease transmission.
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